Omnicell Beheer
Beheer criteriumcontroles 2/4
De CEO Omnicell is Randy Lipps, benoemd in Sep1992, heeft een ambtstermijn van 32.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 11.02M, bestaande uit 7.4% salaris en 92.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.14% van de aandelen van het bedrijf, ter waarde $ 23.27M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 4.4 jaar.
Belangrijke informatie
Randy Lipps
Algemeen directeur
US$11.0m
Totale compensatie
| Percentage CEO-salaris | 7.4% |
| Dienstverband CEO | 32.2yrs |
| Eigendom CEO | 1.1% |
| Management gemiddelde ambtstermijn | 2.8yrs |
| Gemiddelde ambtstermijn bestuur | 4.4yrs |
Recente managementupdates
Recent updates
Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next
Nov 02
Omnicell Q3 Earnings: Look At The Growth Segment
Nov 01Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Oct 31Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Oct 07Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?
Feb 28Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)
Jan 15We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt
Jan 01Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?
Nov 17Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers
Nov 03Omnicell launches Specialty Pharmacy Services
Oct 11Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly
Sep 30Omnicell says advance services to drive profitable growth in long-run: Investor Day
Sep 20Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Sep 15Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger
Aug 31Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook
Aug 04Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?
Aug 03Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio
Jul 21We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease
Jun 27Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$18m |
| Jun 30 2024 | n/a | n/a | -US$21m |
| Mar 31 2024 | n/a | n/a | -US$21m |
| Dec 31 2023 | US$11m | US$813k | -US$20m |
| Sep 30 2023 | n/a | n/a | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$8m | US$804k | US$6m |
| Sep 30 2022 | n/a | n/a | US$48m |
| Jun 30 2022 | n/a | n/a | US$61m |
| Mar 31 2022 | n/a | n/a | US$72m |
| Dec 31 2021 | US$8m | US$768k | US$78m |
| Sep 30 2021 | n/a | n/a | US$80m |
| Jun 30 2021 | n/a | n/a | US$60m |
| Mar 31 2021 | n/a | n/a | US$35m |
| Dec 31 2020 | US$8m | US$721k | US$32m |
| Sep 30 2020 | n/a | n/a | US$38m |
| Jun 30 2020 | n/a | n/a | US$49m |
| Mar 31 2020 | n/a | n/a | US$69m |
| Dec 31 2019 | US$7m | US$711k | US$61m |
| Sep 30 2019 | n/a | n/a | US$54m |
| Jun 30 2019 | n/a | n/a | US$48m |
| Mar 31 2019 | n/a | n/a | US$38m |
| Dec 31 2018 | US$6m | US$690k | US$38m |
| Sep 30 2018 | n/a | n/a | US$54m |
| Jun 30 2018 | n/a | n/a | US$48m |
| Mar 31 2018 | n/a | n/a | US$44m |
| Dec 31 2017 | US$5m | US$669k | US$31m |
Compensatie versus markt: De totale vergoeding ($USD 11.02M ) Randy } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.37M ).
Compensatie versus inkomsten: De vergoeding van Randy is gestegen terwijl het bedrijf verliesgevend is.
CEO
Randy Lipps (67 yo)
32.2yrs
Tenure
US$11,022,072
Compensatie
Mr. Randall A. Lipps, also known as Randy, founded Omnicell, Inc. in September 1992 and has been its Chief Executive Officer and President since October 2002. Mr. Lipps had been Executive Chairman and Exec...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 32.2yrs | US$11.02m | 1.14% $ 23.3m | |
| Executive VP & CFO | 1.4yrs | US$5.16m | 0.024% $ 482.6k | |
| Executive VP | 3.3yrs | US$3.06m | 0.018% $ 365.9k | |
| Executive VP & COO | less than a year | geen gegevens | geen gegevens | |
| VP, Chief Accounting Officer & Corporate Controller | less than a year | geen gegevens | geen gegevens | |
| Senior VP & Chief Information Officer | 5.2yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior VP & Chief People Officer | 1.4yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Global Operations | less than a year | geen gegevens | geen gegevens | |
| Senior VP & GM of International | 2.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Quality & Product Regulatory | 2.8yrs | geen gegevens | geen gegevens | |
| Chief of Staff | 7.3yrs | geen gegevens | geen gegevens |
2.8yrs
Gemiddelde duur
50yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van OMCL wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 32.2yrs | US$11.02m | 1.14% $ 23.3m | |
| Independent Director | less than a year | geen gegevens | 0.018% $ 374.3k | |
| Independent Director | 11.8yrs | US$328.81k | 0.15% $ 3.1m | |
| Director Emeritus | less than a year | US$286.45k | geen gegevens | |
| Independent Director | 5.7yrs | US$322.67k | 0.087% $ 1.8m | |
| Lead Independent Director | 10.8yrs | US$341.69k | 0.082% $ 1.7m | |
| Independent Director | 3.3yrs | US$301.80k | 0.025% $ 507.3k | |
| Independent Director | 5.5yrs | US$297.77k | 0.035% $ 710.6k | |
| Independent Director | 2.5yrs | US$279.13k | 0.022% $ 445.2k | |
| Independent Director | 1.3yrs | US$173.92k | 0.018% $ 358.1k |
4.4yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van OMCL wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).